Atul Bioscience is an API manufacturer based in India. It holds 8 active US drug master files and 3 valid CEPs across a filed portfolio of 7 molecules. Customs aggregates show $2.7M of exports covering 98 molecules to 16 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Ambernath (East), India | 3016575313 |
| Molecule | Regulators | Docs |
|---|---|---|
| Metoprolol | SFDA (Saudi Arabia), US FDA | 3 |
| Losartan | EDQM, US FDA | 2 |
| Valaciclovir | EDQM, US FDA | 2 |
| Venlafaxine | EDQM, US FDA | 2 |
| Acyclovir | US FDA | 1 |
| Desvenlafaxine | US FDA | 1 |
| Fluconazole | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 1 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $28K | 8 |
| 2025 | Not reported | $2.7M | 16 |
| 2024 | Not reported | $2.4M | 18 |
| 2023 | Not reported | $2.9M | 19 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Atul Bioscience comes back tiered against every other supplier able to file there.
Start for free